Your browser doesn't support javascript.
loading
YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Su, Ganglin; Liu, Tianshu; Han, Xiaohong; Sun, Hao; Che, Wenan; Hu, Kun; Xiao, Junwen; Li, Yanfeng; Liu, Yuchen; Li, Wujiao; Mei, Hongbing.
Afiliação
  • Su G; Department of Urology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Liu T; Shantou University Medical College, Shantou, China.
  • Han X; Key Laboratory of Medical Reprogramming Technology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Sun H; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Che W; Department of Urology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Hu K; Department of Urology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Xiao J; Department of Urology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Li Y; Key Laboratory of Medical Reprogramming Technology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Liu Y; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Li W; Hunan Key Laboratory of Economic Crops Genetic Improvement and Integrated Utilization, School of Life Sciences, Hunan University of Science and Technology, Xiangtan, China.
  • Mei H; Department of Urology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
Front Pharmacol ; 12: 709548, 2021.
Article em En | MEDLINE | ID: mdl-34512342

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China